Amniotic membrane surgery

Current Opinion in Ophthalmology

Volumn 12, Issue 4, 2001, Pages 269-281

  Sippel, Kimberly C ^a   Ma, Joseph J K ^a   Foster, C Stephen ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION; BASEMENT MEMBRANE; CONJUNCTIVA DISEASE; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA STROMA; CORNEA ULCER; EYE SURGERY; HUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; TRANSPLANTATION; TREATMENT INDICATION;

AMNION; CONJUNCTIVAL DISEASES; CORNEAL DISEASES; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; HUMANS; PTERYGIUM; STEM CELL TRANSPLANTATION;

EID: 0034892812     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200108000-00006     Document Type: Review

References (121)

1. Plastic repair of conjunctival defects with fetal membrane
2. Amniotic membrane grafts in caustic burns of the eye
3. Placental membranes as a conjunctival substitute
4. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas
5. Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study
6. A pilot study identifying type V collagenolytic activity in human amniotic fluid
7. Localization of type IV and V collagens in the stroma of human amnion
8. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunetiva
9. Amniotic membrane transplantation for persistent epithelial defects with ulceration
10. Bacterial contamination of amniotic membrane
11. Use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface
12. Amniotic membrane transplantation in ophthalmology (fresh v preserved tissue)
13. Amniotic membrane transplantation
14. Cryopreserved human amniotic membrane for ocular surface reconstruction
15. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane
16. Human amniotic membrane after different cryopreservation methods
17. Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface
18. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells
19. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers
20. Histocompatibility antigens, transferrin receptors and extra-embryonic markers of human amniotic epithelial cells in vitro
21. Interferon-gamma induces class I HLA and beta 2-microglobulin expression by human amnion cells
22. Human amnion cells: Modulation of expression of specific antigens
23. Amnion membrane epithelial cells express class I HLA and contain class I HLA mRNA
24. Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G
25. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers
26. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers
27. Amniotic membrane transplantation for ocular surface reconstruction
28. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera
29. Amniotic membrane transplantation for severe neurotrophic corneal ulcers
30. Histopathological study of amniotic membrane after transplantation
31. Crosslinked amniotic membrane for corneal surface reconstruction
32. Chemotaxis of human gingival epithelial cells to laminin. A mechanism for epithelial cell apical migration
33. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion
34. Adhesion of regenerating corneal epithelium. The role of basement membrane
35. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane
36. Basement membrane and human epidermal differentiation in vitro
37. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
38. Conjunctival epithelial cell differentiation on amniotic membrane
39. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
40. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
41. Role of growth factors for ocular surface reconstruction after amniotic membrane transplantation
42. Growth factor mRNA and protein in preserved human amniotic membrane
43. The effect of amniotic membrane transplantation on limbal and corneal epithelial cell proliferation during corneal wound healing
44. Mitotic and wound-healing activities of the corneal epithelium: Effect of sensory denervation
45. Expression of Neurotrophin and their receptors by human limbal epithelial cells expanded on amniotic membrane culture
46. Neurotrophic function of conditioned medium from human amniotic epithelial cells
47. Factors secreted by human amniotic epithelial cells promote the survival of purified rat retinal ganglion cells
48. Corneal substance-P-ergic innervation in HSV-1 induced ulcerating keratitis before and after amniotic membrane transplantation in mice
49. Conjuntival epithelial cells cultured on human amniotic membrane fail to transdifferentiate into corneal epithelial-type cells
50. Ex vive preservation and expansion of human limbal epithelial progenitor cells by amniotic membrane
51. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits
52. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane
53. Amniotic membrane can prolong the survival of human pancreatic cells
54. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn
55. Modulation of acute inflammation and keratocyte death by suturing, brood, and amniotic membrane in PRK
56. Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits
57. Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy
58. Effects of amniotic membrane on epithelial wound healing and stromal remodelling after excimer laser keratectomy in rabbit cornea
59. Immunosuppressive properties of human amniotic membrane
60. Amniotic membrane confers immune privilege on corneal allografts when placed at a non-privileged site
61. Suppression of interleukin 1 alpha and interleukin 1 beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix
62. Amniotic membrane down-regulates chemokine expression in human keratocytes
63. cDNA macroarray used to analyse the gene expression change in human corneal epithelium on amniotic membrane
64. The cytokines studies of organotypic cultures of ocular surface epithelium on amniotic membrane
65. Influence of amniotic membrane transplantation on neutrophils in the HSV infected cornea
66. Improvement of murine herpes simplex keratitis by amniotic membrane transplantation is associated with reduced inflammatory cytokine production
67. Amniotic membrane transplantation improves HSV-1 keratitis: Is this a local or systemic effect?
68. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix
69. Suppression of TGF beta signalling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane
70. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane
71. Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis
72. The gene expression of MMPs and iNOS in the human corneal epithelium cultured with amniotic membrane extract
73. Down-regulation of metalloproteinases and inducible nitric oxide synthase in keratocyte cultured with amniotic membrane extract
74. Overexpression of collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3), and downregulation of urokinase plasminogen activator (uPA) in human normal conjunctival and conjunctivochalasis cultured on amniotic membrane stromal matrix
75. Combined use of an amniotic membrane and tissue adhesive in treating corneal perforation: A case report
76. Use of human fibrin glue and amniotic membrane transplant in corneal perforation
77. Repair of scleral perforation with preserved scleral and amniotic membrane in Marfan's syndrome
78. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency
79. Amniotic membrane transplantation or conjunctival limbal autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries
80. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction
81. Surgical treatment of children blinded by Stevens-Johnson syndrome
82. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome
83. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns
84. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation
85. Ocular surface reconstruction in ocular cicatricial pemphigoid
86. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome
87. Ocular surface reconstruction with amniotic membrane and living-related corneal/conjunctival transplantation for severe cases of Stevens-Johnson syndrome
88. Outcomes of limbal stem cell transplantation in patients with immunologically-mediated ocular surface disorders
89. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome
90. Limbal autotransplantation in the acute and chronic phases of severe chemical injuries
91. Amniotic membrane transplantation for ocular surface reconstruction in chemical burn
92. Amniotic membrane transplantation for acute chemical or thermal burns
93. Amniotic membrane transplantation in acute chemical and thermal injury
94. Thermal and chemical burns
95. Amniotic membrane transplantation in conjunctival surface reconstruction: A prospective study
96. Amniotic membrane transplantation for conjunctival surface reconstruction
97. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments
98. Human amniotic membrane in the reconstruction of the ocular surface
99. Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs
100. Amniotic membrane graft for primary pterygium: Comparison with conjunctival autograft and topical mitomycin C treatment
101. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision
102. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia
103. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon
104. Amniotic membrane transplantation for symptomatic bullous keratopathy
105. Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma
106. Development of a newly designed double-fixed Seoul-type keratoprosthesis
107. Allo-limbal transplantation in patients with limbal stem cell deficiency
108. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency
109. Limbal autograft transplantation for ocular surface disorders
110. Limbal allografting from related live donors for corneal surface reconstruction
111. Limbal autografting: Comparison of results in the acute and chronic phases of ocular surface burns
112. Limbal transplantation
113. Limbal transplantation in the management of chronic contact-lens- associated epitheliopathy
114. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns
115. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders
116. Human allograft limbal transplantation for corneal surface reconstruction
117. Limbal autograft reconstruction after conjunctival squamous cell carcinoma
118. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium
119. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells
120. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease
121. Use of autologous limbal epithelial cells cultured on amniotic membranes for unilateral stem cell deficiency